Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Selitrectinib

🥰Excellent
Catalog No. T7435Cas No. 2097002-61-2
Alias LOXO-195

Selitrectinib (LOXO-195) is a potent and selective inhibitor of the receptor tyrosine kinases(TRK)( TrkA and TrkC with IC50s of 0.6 and <2.5 nM, respectively).

Selitrectinib

Selitrectinib

🥰Excellent
Purity: 99.83%
Catalog No. T7435Alias LOXO-195Cas No. 2097002-61-2
Selitrectinib (LOXO-195) is a potent and selective inhibitor of the receptor tyrosine kinases(TRK)( TrkA and TrkC with IC50s of 0.6 and <2.5 nM, respectively).
Pack SizePriceAvailabilityQuantity
1 mg$34In Stock
5 mg$80In Stock
10 mg$122In Stock
25 mg$239In Stock
50 mg$355In Stock
100 mg$471In Stock
1 mL x 10 mM (in DMSO)$85In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Selitrectinib"

Select Batch
Purity:99.83%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Selitrectinib (LOXO-195) is a potent and selective inhibitor of the receptor tyrosine kinases(TRK)( TrkA and TrkC with IC50s of 0.6 and <2.5 nM, respectively).
Targets&IC50
TrkC:<2.5 nM, TrkA:0.6 nM
In vivo
Selitrectinib (≥30 mg/kg) reduces tumor growth in TrkA-dependent KM12, as well as NIH 3T3 ΔTrkA, ΔTrkA + TrkAG595R, and ΔTrkA + TrkAG667C mouse xenograft models.
Animal Research
Each cell line (2–5×10e6 cells) was injected subcutaneously into female nu/nu NCr mice age 7–9 weeks and allowed to grow to ~100–200 mm3 (efficacy) or ~ 500mm3 (PK-PD) prior to randomization by tumor size and treatment with each inhibitor by oral gavage.?For PK-PD analysis, animals were dosed for 3 days, followed by euthanasia, excision of tumors and collection of plasma.?Phospho-TRK levels in tumor lysates were determined by ELISA assay, while plasma inhibitor levels were determined by LC-MS/MS.?For efficacy analysis, animals were dosed by oral gavage, and body weight and tumor size were monitored at regular intervals.
AliasLOXO-195
Chemical Properties
Molecular Weight380.42
FormulaC20H21FN6O
Cas No.2097002-61-2
Smiles[H][C@]12CCCN1c1ccn3ncc(C(=O)N[C@H](C)CCc4ncc(F)cc24)c3n1
Relative Density.1.51 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 65 mg/mL (170.86 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6287 mL13.1434 mL26.2867 mL131.4337 mL
5 mM0.5257 mL2.6287 mL5.2573 mL26.2867 mL
10 mM0.2629 mL1.3143 mL2.6287 mL13.1434 mL
20 mM0.1314 mL0.6572 mL1.3143 mL6.5717 mL
50 mM0.0526 mL0.2629 mL0.5257 mL2.6287 mL
100 mM0.0263 mL0.1314 mL0.2629 mL1.3143 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Selitrectinib | purchase Selitrectinib | Selitrectinib cost | order Selitrectinib | Selitrectinib chemical structure | Selitrectinib in vivo | Selitrectinib formula | Selitrectinib molecular weight